修飾されたSaengmaeksanは,6つのハーブを含むハーブ剤で,RhoA/Rhoキナーゼ媒介による血管リラックスによって高血圧を改善します
Young Mi Seok1, Hye-Lin Kim2,3, Hyo In Kim4
1Department of Industry Promotion, National Institute for Korean Medicine Development, Gyeongsan, Korea.
Integrative medicine research
|September 2, 2025
まとめ
改造されたSaengmaeksanのハーブ製薬 (mSMS) は,RhoA/Rho- kinase経路を阻害し,血管損傷を減らすことで高血圧のモデルで血圧を効果的に低下させます. この天然化合物は高血圧の治療に 有望な効果を示しています
科学分野:
- 薬理学について
- 薬草 の 薬
- 心血管研究
背景:
- サングメクサンは 韓国の伝統的なハーブ製の調理法です
- 特定のハーブ成分を用いた改造された配方 (mSMS) が開発された.
- この研究は,mSMSの抗高血圧効果を評価することを目的とした.
研究 の 目的:
- mSMSのインビボおよびエクビボ抗高血圧効果を調査する.
- mSMSの作用の基礎となる分子メカニズムを解明する.
- mSMSの血管,酸化ストレス,腎臓の保護効果を評価する.
主な方法:
- l- NAMEによる高血圧マウスと自発的な高血圧ラット (SHR) の抗高血圧効果を評価した.
- 臓器浴と大動脈組織学による血管効果の評価
- 酸化ストレス,腎臓の保護,分子経路 (RhoA/Rho kinase) を様々な測定法と染色法で評価した.
主要な成果:
- mSMSは,両方の高血圧モデルにおいて,シストリックとダイアストリックの血圧を有意に低下させた.
- mSMSのエタノール抽出物は優れた有効性を示した.
- mSMSはRhoA/ Rho- kinase経路を阻害し,血管のリラックスを改善し,大動脈壁の厚み,酸化ストレス,腎臓損傷を軽減し,AT1Rの発現を低下させた.
結論:
- mSMSは,RhoA/ Rho- kinase経路を阻害することで強力な抗高血圧効果を示しています.
- mSMSは血管の改造,酸化ストレス,腎臓の保護を提供しています.
- mSMSは,副作用が少ない高血圧に対する新しい多標的治療薬としての可能性を秘めています.
さらに関連する動画
関連する概念動画
01:23Antihypertensive Drugs: Vasodilators
642
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
642
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
871
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
871
01:29Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
01:25Antihypertensive Drugs: Direct Renin Inhibitors
817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
911
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
911